M Ventures is the strategic, corporate venture capital arm of Merck KGaA, Darmstadt, Germany. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘ KGaA, Darmstadt, Germany's core business areas. From our headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by great entrepreneurs. M Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. M Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck KGaA, Darmstadt, Germany's science and technology base.
Location: Netherlands, North Holland, Amsterdam
Employees: 11-50
Investment Type: Venture Capital
Investment Stage: Pre-Seed; Seed; Series A
Portfolio 76
| Date | Name | Website | Total Raised | Location |
| 16.07.2023 | DNA SCRIPT | dnascript.... | $311.17M | - |
| 16.07.2023 | Astraveus | astraveus.... | $29.1M | France, Il... |
| 14.04.2023 | ImmuneBrid... | immunebrid... | $12M | United Sta... |
| 12.03.2023 | Iktos | iktos.ai | $16.62M | France, Il... |
| 21.02.2023 | Calypso Bi... | calypsobio... | $55.8M | Netherland... |
| 18.02.2023 | Unisers | unisers.ch | $14M | Switzerlan... |
| 08.11.2022 | Concerto B... | concertobi... | $47.54M | United Sta... |
| 08.11.2022 | Hans Scham... | galecto.co... | $154.5M | - |
| 08.11.2022 | Immunitas ... | immunitast... | $97M | United Sta... |
| 08.11.2022 | FoRx Thera... | forxtherap... | $12.11M | Switzerlan... |
Show more
News 51
| Date | Title | Description |
| 29.01.2022 | Future Fertility Raises Series A to Progress First-In-Class ... | First company to develop an AI product to predict egg viability with potential to significantly impr... |
| 11.12.2021 | DNA Script Raises $165M in Oversubscribed Series C Financing... | New Funding, Targeted to Accelerate Application Expansion and Platform Commercialization, Brings Tot... |
| 11.12.2021 | Altoida Launches 5-Year Multi-Center Alzheimer’s Study with ... | Research collaboration will identify new opportunities in the fight against Alzheimer’s and further ... |
| 11.12.2021 | NanoSyrinx announces oversubscribed £6.2M Seed+ funding roun... | NanoSyrinx has raised a further £6.2m of seed financing, co-led by incoming Octopus Ventures and exi... |
| 11.12.2021 | AI Chip Innovator MemryX Hires Veteran Semiconductor Leader ... | Keith Kressin appointed as new president and CEO |
| 11.12.2021 | Altoida Awarded FDA Breakthrough Designation for Development... | Breakthrough Designation will advance the development of industry’s first predictive diagnostic devi... |
| 11.12.2021 | DNA Script Obtains CE Mark for SYNTAX DNA Printing Platform | DNA Script, a leader in Enzymatic DNA Synthesis (EDS), announced the CE marking of its SYNTAX System... |
| 11.12.2021 | Merck KGaA, Darmstadt, Germany, Expands Corporate Venture Fu... | Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced the expans... |
| 11.12.2021 | iOmx Therapeutics raises EUR 65 million in Series B round | Martinsried / Munich, Germany, 5 October, 2021: iOmx Therapeutics AG (iOmx), a biopharmaceutical com... |
| 22.11.2021 | Xilio Therapeutics Announces Closing of Initial Public Offer... | Xilio Therapeutics, Inc. today announced the closing of its previously announced initial public offe... |
Show more
Mentions in press and media 44
| Date | Title | Description | Source |
| 17.04.2024 | Mosa Meat Secures €40M to Revolutionize Cultivated Beef Mark... | Mosa Meat, a Dutch cultivated meat company, has secured a whopping €40 million in funding to acceler... | parsers.vc... |
| 16.04.2024 | Mosa Meat Secures €40M in Funding to Expand Production and S... | 5 Mins Read Dutch cultivated meat pioneer Mosa Meat has raised €40M ($42.4M) in a new funding round ... | greenqueen... |
| 16.04.2024 | Maastricht-based Mosa Meat raises €40 million to help bring ... | - | eu-startup... |
| 05.04.2024 | Nucleai Revolutionizes Clinical Trials with $14M Funding Boo... | Nucleai, a pioneer in spatial AI biomarkers, has secured a hefty $14M in funding led by M Ventures, ... | parsers.vc... |
| 04.04.2024 | Chicago AI-based biotech startup Nucleai raises $14 million ... | - | bizjournal... |
| 03.04.2024 | Nucleai Secures $14M to Enhance Clinical Trial Enrollment wi... | What You Should Know: – Nucleai, a pioneer in spatial AI biomarkers raises $14M in funding led by M ... | hitconsult... |
| 03.05.2023 | Dutch-based Anavo Therapeutics secures €8.5M to systematical... | Leiden-based Anavo Therapeutics, a company that claims to be the first to systematically drug phosph... | siliconcan... |
| 09.03.2023 | Iktos raises €15.5 million Series A round for AI drug discov... | French start-up Iktos has raised a €15.5 million Series A round fuelling its launch of its drug disc... | tech.eu/20... |
| 17.02.2023 | Unisers secures $14M to develop defect-detecting tools in ch... | startuptic... | |
| 07.07.2022 | Tignis and M Ventures/Merck, KGaA, Darmstadt, Germany Announ... | Introductions for Tignis and M Ventures Accelerated through Global Semiconductor Industry Associatio... | einpresswi... |
Show more